Neurogene (NGNE) Other financing activities (2013 - 2025)
Neurogene (NGNE) reported Other financing activities of $241000.0 for Q4 2025, down 94.38% on a YoY basis from $4.3 million in Q4 2024, and down 94.38% quarter-over-quarter from $4.3 million in Q4 2024.
Neurogene (NGNE) Other financing activities (2013 - 2025) Analysis & Trends
Neurogene has reported Other financing activities for 7 years, with the latest figure at $241000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other financing activities fell 94.38% year-over-year to $241000.0; the trailing twelve-month figure through Dec 2025 stood at $241000.0 (down 94.38% YoY), and the FY2025 full-year result was $241000.0, down 94.38% from the prior year.
- Other financing activities for Q4 2025 stood at $241000.0, down from $4.3 million in the prior quarter.
- The five-year high for Other financing activities was $4.3 million in Q1 2024, with the low at -$4.3 million in Q3 2024.
- Historically, Other financing activities has averaged $646857.1 across 3 years, with a median of $241000.0 in 2025.
- The largest YoY upside for Other financing activities was 318.61% in 2024 against a maximum downside of 330.36% in 2024.
- Neurogene's Other financing activities stood at -$2.0 million in 2023, then jumped by 318.61% to $4.3 million in 2024, then tumbled by 94.38% to $241000.0 in 2025.
- The last three Other financing activities figures came in at $241000.0 (Q4 2025), $4.3 million (Q4 2024), and -$4.3 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 241,000.00 |
| Dec 31, 2025 | 241,000.00 |
| Dec 31, 2024 | 4.29 Mn |
| Dec 31, 2024 | 4.29 Mn |
| Sep 30, 2024 | -4.29 Mn |
| Sep 30, 2024 | -4.29 Mn |
| Mar 31, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.29 Mn |
| Dec 31, 2023 | -1.96 Mn |
| Dec 31, 2023 | -1.96 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Dec 31, 2016 | 161,000.00 |
| Dec 31, 2016 | 161,000.00 |
| Dec 31, 2015 | 147,000.00 |
| Dec 31, 2015 | 147,000.00 |
| Sep 30, 2015 | 5.99 Mn |
| Sep 30, 2015 | 5.99 Mn |